Amgen Applies Contract Pharmacy Restrictions to Federal Grantees

Beginning March 19, 2024, Amgen will apply its contract pharmacy restriction policy to all covered entity types, including previously exempted federal grantees.  Amgen’s policy applies to self-administered Amgen products—Repatha®, Enbrel®,…